Evidence map›Paper›PMID 41324692›Full record

ArticleIntensive care medicine2026

Temporal robustness of biomarker-based classification algorithms for sepsis.

Emma Rademaker, Rombout B E van Amstel, Said El Bouhaddani, Marc J M Bonten, Lennie P G Derde, Lonneke van Vught, Tom van der Poll, Lieuwe D J Bos, Harm-Jan de Grooth, Olaf L Cremer

Abstract read
In one paragraph

Article in Intensive care medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emma RademakerJulius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. e.rademaker-2@umcutrecht.nl.ORCID 0000-0001-5143-5723
Rombout B E van AmstelDepartment of Intensive Care, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Said El BouhaddaniJulius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Marc J M BontenJulius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Lennie P G DerdeJulius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Lonneke van VughtJulius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Tom van der PollCenter for Experimental and Molecular Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Lieuwe D J BosDepartment of Intensive Care, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Harm-Jan de GroothDepartment of Intensive Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Olaf L CremerDepartment of Intensive Care, University Medical Center Utrecht, Utrecht, The Netherlands.

Funding

Center for Translational Molecular Medicine 04I-201
6 · The paper itself

Abstract

purposeHeterogeneity of the host response in sepsis hampers development of effective treatments. Several immunobiologically distinct subphenotypes (or endotypes) have been identified using data-driven analyses of single-timepoint biomarker data, but their temporal stability remains uncertain due to dynamic biology and statistical limitations.

methodsWe analyzed data from 345 sepsis patients across two ICU cohorts. 30 immune biomarkers were measured every 8 h for up to 7 days. Latent profile analysis was used to identify classes upon admission and re-classify patients at later timepoints. Temporal robustness was assessed by (1) inter-class transition rates, and (2) intra-class cohesion (regardless of label) using the Rand Index (RI).

resultsAt ICU admission, three immune profiles were identified: profile A (149 patients, 43%) reflected adaptive immune activation (elevated IL-4, IL-5, RANTES, and GM-CSF); profile B (60 patients, 17%) a hyperinflammatory state (high IL-6, IL-8, IL-1Ra, and low protein C); and profile C (136 patients, 39%) broadly attenuated inflammation. By 48 h, the prevalences of A and B declined to 31% and 13%, while C increased to 56%. Inter-class transitions occurred most in patients assigned to A (41% of all 8-hourly transitions), compared to 39% and 22% for B and C. Intra-class cohesion across intervals was poor (median RI 65%, IQR 62-64%), indicating that patients classified together at admission did not remain consistently together.

conclusionSepsis patients were frequently reclassified across immune profiles over short intervals, with approximately one-third of subgroup peers changing at each timepoint. This instability challenges the clinical utility of biomarker-derived endotypes.

Indexed as

AlgorithmsBiomarkersSepsisAgedClassification AlgorithmsCytokinesFemaleHumansIntensive Care UnitsMaleMiddle AgedTime FactorsBiomarkersCytokinesBiomarkerImmune profileSepsisSubphenotypesTemporal stability

Identifiers

PMID41324692
PMCPMC12852201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.